| Market Cap | 4.48M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -44.16k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 4.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -60.00% |
| Recommedations | - | Quick Ratio | - | Shares Outstanding | 74.64M | 52W Low Chg | 471.00% |
| Insider Own | 66.99% | ROA | - | Shares Float | 24.64M | Beta | 3.10 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | 5.49K/4.14K | Price | 0.06 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 14,817 | Target Price | - |
| Oper. Margin | - | Earnings Date | Nov 11 | Volume | 60 | Change | 0.00% |
Hong Yuan Holding Group does not have significant operations. Previously, it was engaged in the development and commercialization of bio-based resins. The company was formerly known as Cereplast, Inc. and changed its name to Hong Yuan Holding Group in June 2021. Hong Yuan Holding Group was incorporated in 2001 and is based in Zhengzhou, China.
